Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force

For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and weight gain with some SUs have led to discussion on...

詳細記述

保存先:
書誌詳細
出版年:Indian J Endocrinol Metab
主要な著者: Kalra, Sanjay, Bahendeka, Silver, Sahay, Rakesh, Ghosh, Sujoy, Md, Fariduddin, Orabi, Abbas, Ramaiya, Kaushik, Al Shammari, Sameer, Shrestha, Dina, Shaikh, Khalid, Abhayaratna, Sachitha, Shrestha, Pradeep K., Mahalingam, Aravinthan, Askheta, Mazen, A. Rahim, Aly Ahmed, Eliana, Fatimah, Shrestha, Hari K., Chaudhary, Sandeep, Ngugi, Nancy, Mbanya, Jean Claude, Aye, Than Than, Latt, Tint Swe, Akanov, Zhanay A., Syed, Abbas Raza, Tandon, Nikhil, Unnikrishnan, A. G., Madhu, S. V., Jawa, Ali, Chowdhury, Subhankar, Bajaj, Sarita, Das, Ashok Kumar
フォーマット: Artigo
言語:Inglês
出版事項: Medknow Publications & Media Pvt Ltd 2018
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
https://ncbi.nlm.nih.gov/pubmed/29535952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijem.IJEM_556_17
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料